losartan has been researched along with Diseases, Metabolic in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagae, SC | 1 |
| Lubaczeuski, C | 1 |
| Zacharias, P | 1 |
| Bonfleur, ML | 1 |
| Franci, CR | 1 |
| Sanvitto, GL | 1 |
1 other study available for losartan and Diseases, Metabolic
| Article | Year |
|---|---|
Prevention of metabolic disorders and reproductive performance deficits by the blockade of Angiotensin II AT1 receptor in female rats fed with cafeteria diet.
Topics: Adipose Tissue; Angiotensin Receptor Antagonists; Animals; Body Weight; Cholesterol; Diet, High-Fat; | 2013 |